IL17A and thyroid cancer: Studies in peripheral blood, with flow cytometry and IL-17 measurement, associated Th17 with malignant thyroid tumors; however, this lymphocytic subtype still has a controversial role, and little evidence shows an antitumor effect (28, 29, 30).